Drugs / Clostridium butyricum (live)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT07369830 | Oct 2025 → Mar 2029 expected | rectal cancer | Huashan Hospital | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Clostridium butyricum (live) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07369830 ↗ |
| Known as | Meiya | “Clostridium butyricum (live) Tablets(Meiya)” NCT07369830 ↗ |
| Route | Other | “administered into the dysfunctional intestine” NCT07369830 ↗ |